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Abstract 
Review on t(11;19)(q23;p13) KMT2A/SH3GL1, 
with data on clinics, and the genes implicated. 
Identity 
Note 
At least three other translocation t(11;19) involve 
KMT2A: the t(11;19)(q23;p13.1) KMT2A/ELL, the 
t(11;19)(q23;p13.3) KMT2A/MLLT1, and the 
t(11;19)(q23;p13.3) KMT2A/ACER1. 
Clinics and pathology 
Epidemiology 
Only one case to date, a 22-month-old girl with a 
diagnosis of acute myeloid leukemia not otherwise 
specified (So et al., 1997). 






KMT2A is better known as MLL. MLL is a 
transcriptional regulatory factor. MLL regulates 
chromatin-mediated transcription. MLL is a major 
regulator of hematopoesis and embryonic 
development, through regulation of HOX genes 
expression. Translocations involving MLL are 
associated with high-risk de novo or treatment-
related acute myeloid leukemias and 
myelodysplastic syndromes and acute lymphoblastic 
leukemias (review in Huret, 2006). Mutations in 






The gene has previously been named EEN. 
Protein 
The protein, named endophilin-A2, is made of 368 
amino acids (aa) in isoform 1. From N-term to C-
term, it contains a Bin/Amphiphysin/Rvs (BAR) 
domain (aa 18-249), involved in curvature of the cell 
membrane, a coiled-coil domain (protein-protein 
interactions, aa 119-227), and a SH3 domain 
(protein-protein interactions, aa 306-365). 
Endophilin-A2 is involved in clathrin-mediated 
endocytosis. Endophilin-A2 facilitates G1/S cell 
cycle transition of multiple myeloma cells (Huang et 
al., 2014). 




5' KMT2A - 3' SH3GL1. KMT2A exon 6 was fused 
to SH3GL1 exon 2. 
Fusion protein 
Description 
1564 amino acids (1212 from KMT2A, and 352 
from SH3GL1). The fusion protein retains the AT 
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hooks (DNA binding) and the Zinc finger CXXC-
type from KMT2A fused to most of SH3GL1, 
including the BAR domain and the SH3 domain. 
Oncogenesis 
KMT2A/SH3GL1 is localized in the nucleus, while 
SH3GL1 is located in the cytoplasm. 
KMT2A/SH3GL1 may drive to aberrant 
transcriptional regulation. KMT2A/SH3GL1 
increases HOXA7 promoter activity (Liu et al., 
2004). 
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